US$ 29.97
glp 1 gip glucagon triple agonist Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care Targeting GLP-1, GIP & GCG
Description
10.2337/dc08-1355 54 NauckM.WeinstockR

June 2, 2025

Jama 331 , 3848 (2024)

P., Auerbach, P., Bajaj, H

P = 0.017) compared to nonfatal myocardial infarction (HR 0.96

J Clin Hypertens (Greenwich)
